Richard L. Love
Director/Board Member chez CANCER PREVENTION PHARMACEUTICALS INC
Profil
Richard L.
Love's current job(s) include being a Director at Caris Molecular Profiling Institute, Inc., Applied Microarrays LLC, SynDevRx, Inc., Cancer Prevention Pharmaceuticals, Inc., MedTrust Online LLC, Molecular Profiling Institute, Inc., PMed Management LLC, Ascalon Pharmaceuticals, Translational Accelerator LLC, and TVP Management Co. LLC.
Mr. Love's former job(s) include being the President & Chief Executive Officer at ILEX Oncology, Inc. from 1994 to 2004, Chief Executive Officer at Triton Biosciences, Inc. from 1983 to 1991, Chairman at CTI BioPharma Corp.
in 2017, Chairman at ImaRx Therapeutics, Inc. from 2006 to 2009, Chairman at Systems Medicine, Inc., Executive Chairman at CerRx, Inc., Independent Director at PAREXEL International Corp.
from 2002 to 2017, Director at Salutaris Medical Devices, Inc., Director at Ascalon International, Inc., Executive Vice President at Cancer Therapy & Research Center Endowment from 1991 to 1994, and Chief Operating Officer at Translational Genomics Research Institute from 2003 to 2007.
Mr. Love's education history includes an undergraduate degree from Virginia Polytechnic Institute & State University in 1965 and a graduate degree from Virginia Polytechnic Institute & State University in 1967.
Postes actifs de Richard L. Love
| Sociétés | Poste | Début |
|---|---|---|
| CANCER PREVENTION PHARMACEUTICALS INC | Director/Board Member | 01/11/2011 |
| Ascalon Pharmaceuticals | Chief Executive Officer | - |
| PMed Management LLC | Director/Board Member | - |
| Molecular Profiling Institute, Inc. | Director/Board Member | - |
Translational Accelerator LLC
 Translational Accelerator LLC Investment ManagersFinance Translational Accelerator LLC seeks investment opportunities in companies located in the US. The fund targets companies operating in the fields of oncology, neuroscience, developing diagnostics, medical tests or services. It provides financing for early stage capital requirements. | Corporate Officer/Principal | 01/01/2007 |
SynDevRx, Inc.
 SynDevRx, Inc. Miscellaneous Commercial ServicesCommercial Services SynDevRx, Inc. develops treatments for metabolic-related diseases. Its product includes SDX-7320, a polymer conjugate of fumagillol that releases a pharmacologically active small molecule fumagillol derivative in vivo. The company was founded by James M. Shanahan and Bradley J. Carver and is headquartered in Cambridge, MA. | Director/Board Member | - |
Caris Molecular Profiling Institute, Inc.
 Caris Molecular Profiling Institute, Inc. Medical/Nursing ServicesHealth Services Caris Molecular Profiling Institute, Inc. provides research and laboratory testing services. It offers tests to help oncologists to understand and treat cancer patients with personalized treatment plans based on the molecular characteristics of their tumors. The company offers services to the hospitals, physicians, and clinical research sponsors. Caris Molecular Profiling Institute was founded on 1996 and is headquartered in Phoenix, AZ. | Director/Board Member | 03/11/2010 |
Applied Microarrays LLC
 Applied Microarrays LLC Medical SpecialtiesHealth Technology Applied Microarrays, Inc. manufactures custom nucleic acid and protein microarrays. The firm’s solutions include disease applications, point-of-care arrays, high throughput and instrumentation. Its services include manufacturing process, array design and optimization and project management. The company was founded by Alastair Malcolm in 2006 and is headquartered in Tempe, AZ. | Director/Board Member | 18/08/2010 |
TVP Management Co. LLC
 TVP Management Co. LLC Investment ManagersFinance TVP Management Co. LLC (TVP Management) is a venture capital subsidiary of Grayhawk Capital founded in 2006. The firm is headquartered in Phoenix, Arizona. | Private Equity Investor | 01/09/2007 |
| ░░░░░░░░ ░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Anciens postes connus de Richard L. Love
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░░░ ░░░░░░░░ ░░░░░░░░ ░░░░░░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░ ░░░░░ ░░░░░░░░ ░░░░░░ ░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Richard L. Love
| Virginia Polytechnic Institute & State University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 22 |
|---|---|
CTI BioPharma Corp.
 CTI BioPharma Corp. Pharmaceuticals: MajorHealth Technology CTI BioPharma Corp. is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of novel targeted therapies for blood-related cancers. It focuses on evaluating pacritinib, its sole product candidate currently in active development, for the treatment of adult patients with myelofibrosis. The company was founded by James A. Bianco, Jack W. Singer, and Louis A. Bianco in September 1991 and is headquartered in Seattle, WA. | Health Technology |
PAREXEL International Corp.
 PAREXEL International Corp. Miscellaneous Commercial ServicesCommercial Services PAREXEL International Corp. provides biopharmaceutical services. It offers clinical research and logistics, medical communications, consulting, commercialization and advanced technology products and services for pharmaceutical, biotechnology and medical device industries. The company was founded in 1983 and is headquartered in Newton, MA. | Commercial Services |
ILEX Oncology, Inc.
 ILEX Oncology, Inc. BiotechnologyHealth Technology ILEX Oncology, Inc. was a drug development company focused predominantly on accelerated development of drugs for the treatment and prevention of cancer. The company used to offer drug development services on a contract basis to pharmaceutical and biotech companies through its ILEX Oncology Services subsidiary and used to advance a diversified portfolio of anticancer drugs through its ILEX Products subsidiary. It was located in San Antonio, TX. | Health Technology |
| Cancer Therapy & Research Center Endowment | Health Services |
ImaRx Therapeutics, Inc.
 ImaRx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ImaRx Therapeutics, Inc. manufactures biopharmaceutical products. The company develops and manufactures therapies for vascular disorders associated with blood clots based on two programs, thrombolytics and sonoLysis. Its therapeutics products are approved by the US Food, Drug Administration and FDA, for the treatment of acute pulmonary embolism or blood clots in the lungs. The company was founded in 1991 and is headquartered in Los Angeles, CA | Health Technology |
Caris Molecular Profiling Institute, Inc.
Caris Molecular Profiling Institute, Inc. Medical/Nursing ServicesHealth Services Caris Molecular Profiling Institute, Inc. provides research and laboratory testing services. It offers tests to help oncologists to understand and treat cancer patients with personalized treatment plans based on the molecular characteristics of their tumors. The company offers services to the hospitals, physicians, and clinical research sponsors. Caris Molecular Profiling Institute was founded on 1996 and is headquartered in Phoenix, AZ. | Health Services |
Translational Accelerator LLC
Translational Accelerator LLC Investment ManagersFinance Translational Accelerator LLC seeks investment opportunities in companies located in the US. The fund targets companies operating in the fields of oncology, neuroscience, developing diagnostics, medical tests or services. It provides financing for early stage capital requirements. | Finance |
Applied Microarrays LLC
Applied Microarrays LLC Medical SpecialtiesHealth Technology Applied Microarrays, Inc. manufactures custom nucleic acid and protein microarrays. The firm’s solutions include disease applications, point-of-care arrays, high throughput and instrumentation. Its services include manufacturing process, array design and optimization and project management. The company was founded by Alastair Malcolm in 2006 and is headquartered in Tempe, AZ. | Health Technology |
Salutaris Medical Devices, Inc.
 Salutaris Medical Devices, Inc. Medical SpecialtiesHealth Technology Salutaris Medical Devices, Inc. operates as a clinical-stage medical device company. It develops minimally invasive, patient-centric treatments. The firm also develops an investigational ophthalmic treatment for Wet Age-related Macular Degeneration (Wet AMD). The company was founded by Russell J. Hamilton and Laurence J. Marsteller in 2008 and is headquartered in Tucson, AZ. | Health Technology |
SynDevRx, Inc.
SynDevRx, Inc. Miscellaneous Commercial ServicesCommercial Services SynDevRx, Inc. develops treatments for metabolic-related diseases. Its product includes SDX-7320, a polymer conjugate of fumagillol that releases a pharmacologically active small molecule fumagillol derivative in vivo. The company was founded by James M. Shanahan and Bradley J. Carver and is headquartered in Cambridge, MA. | Commercial Services |
Cancer Prevention Pharmaceuticals, Inc.
 Cancer Prevention Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cancer Prevention Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the development of therapeutic agents for the treatment and prevention of certain pre-cancerous conditions, orphan diseases and gastrointestinal conditions. The company’s pipeline consists of Gastrointestinal and Orphan. Cancer Prevention Pharmaceuticals was founded by Dr. Frank Meyskens and Gene Gerner in June 9, 2008 and is headquartered in Tucson, AZ. | Health Technology |
Ascalon International, Inc.
 Ascalon International, Inc. BiotechnologyHealth Technology Ascalon International, Inc. develops oncology drugs. The company was founded by Keith Benson on February 24, 2010 and is headquartered in Scottsdale, AZ. | Health Technology |
Boston Millennia Partners
 Boston Millennia Partners Investment ManagersFinance Boston Millennia Partners (BMP) is a private equity and venture capital subsidiary of Glen Ventures Management, Inc founded in 1997 by Dana Callow. The firm headquartered in Boston, Massachusetts. | Finance |
Translational Genomics Research Institute
 Translational Genomics Research Institute Miscellaneous Commercial ServicesCommercial Services Translational Genomics Research Institute operates as non-profit organization. It focuses on developing earlier diagnoses and smarter treatments. Translational research applies to the development of diagnostics, prognostics, and therapies for cancer, neurological disorders, diabetes, and other complex diseases. The company was founded by Jeffrey M. Trent in 2002 and is headquartered in Phoenix, AZ. | Commercial Services |
Systems Medicine, Inc.
 Systems Medicine, Inc. Pharmaceuticals: OtherHealth Technology Systems Medicine, Inc. develops oncology products by integrating predictive cellular pharmacogenomics. The company is based in Tucson, AZ. The company was founded by Jeffrey E. Jacob. Systems Medicine was acquired by CTI BioPharma Corp. on July 31, 2007 for $35 million. | Health Technology |
| Triton Biosciences, Inc. | |
MedTrust Online LLC
 MedTrust Online LLC Miscellaneous Commercial ServicesCommercial Services MedTrust Online LLC develops online support and connection services for oncologists. It provides Internet-based solution that enables physicians to practice precision medicine. The company was founded by Christopher Yoo on December 3, 2007 and is headquartered in Scottsdale, AZ. | Commercial Services |
TVP Management Co. LLC
TVP Management Co. LLC Investment ManagersFinance TVP Management Co. LLC (TVP Management) is a venture capital subsidiary of Grayhawk Capital founded in 2006. The firm is headquartered in Phoenix, Arizona. | Finance |
CerRx, Inc.
 CerRx, Inc. Medical DistributorsDistribution Services CerRx, Inc. engages in the discovery and development of anticancer drugs for cancer patients. Its products include Fenretinide and Safingol. The company was founded on December 24, 2008 and is headquartered in Lubbock, TX. | Distribution Services |
| Molecular Profiling Institute, Inc. | |
| PMed Management LLC | |
| Ascalon Pharmaceuticals |
